Methyl Alcohol

Methyl Alcohol

SCHEMBL797986

CO.Nc1cc(Cl)c(-c2nc3c(F)cnc(Nc4ccncn4)c3s2)c(Cl)c1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 12/20 0.47
JAK2 O60674 2/20 0.35
CCNA2 P20248 4/20 0.34
CDK2 P24941 4/20 0.34
CCNA1 P78396 4/20 0.34
CDK5 Q00535 3/20 0.32
DYRK1A Q13627 3/20 0.32
CDK5R1 Q15078 3/20 0.32
LCK P06239 1/20 0.31
MPL P40238 1/20 0.31
KDR P35968 1/20 0.30
EGFR P00533 1/20 0.30
ERBB2 P04626 1/20 0.30
JAK1 P23458 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL792675 0.83 TYK2 (0.51) TYK2JAK2CDK2EGFRERBB2
Hydrochloric Acid SCHEMBL11898764 0.83 TYK2 (0.51) TYK2JAK2CDK2EGFRERBB2
SCHEMBL11898778 0.81 TYK2 (0.49) TYK2
Hydrochloric Acid SCHEMBL793483 0.80 TYK2 (0.49) TYK2
SCHEMBL791626 0.77 TYK2 (0.73) TYK2JAK2LCK
Hydrochloric Acid SCHEMBL11898680 0.77 TYK2 (0.72) TYK2JAK2LCK
SCHEMBL793466 0.75 TYK2 (0.59) TYK2JAK2CDK2LCKEGFR
SCHEMBL793110 0.74 TYK2 (0.66) TYK2JAK2CDK2KDRJAK1
SCHEMBL793559 0.74 TYK2 (0.80) TYK2JAK2LCK
SCHEMBL793045 0.73 TYK2 (0.57) TYK2JAK2LCKEGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616072-A1 AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2013-07-24 EP disclosed
WO-2012035039-A1 AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2012-03-22 WO disclosed